Skip to main content

Table 1 Nematocidal and antifungal activity of compounds 5a5z

From: Design, synthesis, and biological activity of novel 1,2,4-oxadiazole derivatives

Compounds

M. incognita

R. solani

Corrected mortality rate (%)a、

Inhibition rate (%)b

5a

33.4 ± 2.7

28.7 ± 1.3

5b

28.9 ± 5.2

15.6 ± 0.7

5c

37.6 ± 8.1

25.2 ± 2.2

5d

26.6 ± 2.0

20.4 ± 1.2

5e

0

18.8 ± 1.7

5f

29.5 ± 2.7

34.6 ± 2.3

5 g

31.3 ± 5.3

16.1 ± 1.1

5 h

29.4 ± 6.1

19.1 ± 0.5

5i

40.3 ± 1.8

23.5 ± 1.6

5j

39.7 ± 4.2

15.0 ± 2.3

5 k

14.7 ± 27

34.7 ± 0.8

5 l

31.3 ± 3.8

22.1 ± 0.8

5 m

48.0 ± 3.7

23.8 ± 3.2

5n

63.3 ± 7.7

29.4 ± 1.0

5o

35.5 ± 2.4

47.0 ± 1.7

5p

25.3 ± 3.7

10.4 ± 0.6

5q

44.8 ± 6.7

26.1 ± 0.8

5r

36.7 ± 5.0

29.1 ± 0.5

5 s

27.3 ± 8.8

13.3 ± 1.6

5t

35.6 ± 3.4

25.8 ± 1.3

5u

40.8 ± 3.4

34.5 ± 2.3

5v

55.0 ± 7.7

34.3 ± 0.3

5w

26.6 ± 4.0

32.9 ± 1.1

5x

47.3 ± 3.8

13.6 ± 3.2

5y

34.6 ± 2.4

39.4 ± 1.4

5z

36.5 ± 2.6

27.8 ± 1.6

Tioxazafen

29.0 ± 4.5

NT

Fluopicolide

100

NT

Azoxystrobin

NT

100

  1. Average of three replicates
  2. NT not tested
  3. a Target compounds 5a-5z at a concentration of 100 μg/mL against J2 of M. incognita
  4. b Target compounds 5a-5z at a concentration of 50 μg/mL against R.solani